3 yr interim RELIANCE study analysis shows long-term CAN tx is safe and effective in CAPS regardless of the underlying mutation and TRAPS. Abs 0812 #ACR22 @RheumNow https://t.co/pgSq1IICJK and https://t.co/Y2NUpgXGPL https://t.co/j9DMFF7V8S

• 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-asso…
• Canakinumab in Patients with Tumor Necrosis Factor Receptor-associated Periodic…

In clinic US guided entheseal biopsy? Abs 1025 at #ACR22 recommends the lateral epicondyle tendon plate in PsA pts. @RheumNow https://t.co/VomyFkecLq

• Entheseal Biopsy Approach: An Ultrasound-guided Method for Retrieval of Enthese…

Exposure to DMARDs prior to ICI treatment was not associated with 2-year crude mortality rates. Abs 0764 #ACR22 @RheumNow https://t.co/WvTy84Si7u https://t.co/X4RvYAVSMC

• No Impact of Prior DMARD Exposures on Mortality in US Veterans with Cancer Trea…

Window of opportunity in PsA CorEvitas registry: Early initiators had more severe disease & worse PROs but if DMARD therapy initiated within 1 yr: RR=2 MDA achievement & higher reduction of CDAI https://t.co/Xm9i7aiq85 Abs#1493 #ACR22 @Rheumnow https://t.co/RAGoHeuSIg

• Impact of Delay of Treatment with Disease Modifying Antirheumatic Drugs (DMARDs…

Performance BASDAI & ASDAS in evaluating PsA axial symptoms? 400+ pts DISCOVER 1&2 Weak correlations w/ peripheral arthritis Moderate/strong correlations w/ fatigue & pain Both perform similarly but do they perform well enough? https://t.co/alnrEXtydp Abs#1037 #ACR22 @Rheumnow https://t.co/Zuf1FruneK

• Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients wit…

Benefits with receiving anabolic agents upfront before antiresoprtives (as opposed to other way around). Shame about lack of access to this sequence currently @RheumNow #ACR22 #osteoporosis https://t.co/S2ttbrVaab

Low likelihood of syndesmophyte formation in PsA but is more likely assoc'd w/ axial involvement radiographically + high CRP. Abs 1014 #ACR22 @RheumNow https://t.co/M5Tc0fd64s https://t.co/e25gwVQKeo

• Is Radiographic Axial Involvement Associated with Syndesmophyte Development Aft…

DISCOVER 1 & 2: Subanalysis of GUS in 181 pts w/ Axial PsA and imaging confirmed SI GUS improves BASDAI, mBASDAI, spinal pain, morning stiffness, and ASDAS from W8 to W24 W24 Response rates BASDAI50 38% BASDAI70 20% https://t.co/MrS8atrIOI Abs#1035 #ACR22 @Rheumnow https://t.co/wMDkO1Qak9

• Efficacy of Guselkumab in Three Cohorts of Biologic-Naïve PsA Patients with Axi…

Most important point from the Great Debate on treating pre-RA. Are we really treating to prevent RA or are we simply delaying RA onset? I don't think there is enough data to treat pre-clinical RA with our current arsenal of DMARDs. What would you do? @RheumNow #ACR22

The Great Debate! Should you treat pre-clinical RA? ACPA+ ~40% did not convert to clinical RA RF+/ACPA+ least likely to seroconvert to negative @RheumNow #ACR22 https://t.co/djVPKDdWjz

Dr. Talabi: Progestin-only has⬇️thrombotic risk vs. estrogen👇 ‼️Safety signal for DMPA/depo shot bec. might be more prothrombotic vs. other progestin methods; addt'l studies needed; recommend to avoid in aPL+ for now #ACR22 @Rheumnow https://t.co/pQe5H8wqvi

"Less than 1 in 6 rheumatology guideline recommendations are informed by head-to-head RCTs." #ACR22 abst#1284 @rheumnow Comparative Effectiveness Randomized Controlled Trials in Rheumatology Guidelines https://t.co/l5NzzcHRSA

• Comparative Effectiveness Randomized Controlled Trials in Rheumatology Guidelin…

Most prevalent locations of enthesitis on the global SpA population are the lumbar spinous processes, the thoracic spinous processes & Achilles tendon. MEI & MASES best capturing axSpA enthesitis. MEI & SPARCC best in pSpA & PsA. Abs 1004 #ACR22 @RheumNow https://t.co/6IbusqHI5d https://t.co/5y5NFthyJz

• SPARCC, MASES, LEI and MEI Indexes Capture Different Patients with Enthesitis i…

Tofacitinib in new-onset PMR: Nice mechanistic data - all the right things line up - leading to promising proof-of-concept study (EAST PMR) Plenty to tease apart here but real promise to explore in bigger studies ABST1107 #ACR22 @RheumNow https://t.co/s4ts7lrVtZ

Dr Iyer shares how ROSCE can teach trainees #telerheumatology using video visits: ☝️ Relevant to career, enhanced self-directed learning ☝️Accdg to ROSCE results, improvement needed on telemed focused exams 🤓Video ROSCE as T-L strat, eval #ACR22 @RheumNow #MedEd @rheumarhyme https://t.co/kZXMrbwtzW